BlueFive Capital announced it has closed its $3 billion Onyx Fund I, a vehicle registered with the Abu Dhabi Global Market that will pursue opportunistic technology and growth capital investments across the United States and Europe. The firm said the fund will focus on businesses operating at the frontier of innovation, with an emphasis on artificial intelligence, biotechnology, and advanced computing, where it sees disruptive potential increasingly translating into scalable commercial applications.
The firm positioned Onyx as a strategy for periods of rapid technological change, when category leaders can emerge quickly, and capital can be deployed during moments of market dislocation or acceleration. By targeting both “computational” and “biological” intelligence, BlueFive signals a mandate that spans foundational AI infrastructure and applications, as well as life sciences platforms, where data, automation, and new modalities are reshaping discovery and development cycles.
BlueFive said the fund is anchored by opportunistic sovereign capital from across the Gulf Cooperation Council, which it framed as a strategic alignment between long-duration regional investment priorities and high-conviction exposure to technology disruption in Western markets. That anchor base can matter in practice because it may support larger check sizes, longer underwriting horizons, and a willingness to pursue complex opportunities that sit at the intersection of deep tech, regulation, and commercialization.
The close also suggests BlueFive is moving into an active deployment phase. The firm said it expects to make several technology and biotechnology investments in the U.S. in the coming months, indicating that the fundraising milestone is intended to translate quickly into executed deals rather than a prolonged ramp-up.
On leadership, BlueFive is led by founder and chief executive Hazem Ben Gacem, who is widely known in the region’s private equity ecosystem for his long tenure at Investcorp, including serving as co CEO, and for building and overseeing investment activity across multiple geographies and strategies during that period. BlueFive has presented its platform as a global investment firm based in Abu Dhabi with ambitions across private markets, and the Onyx Fund adds a dedicated pool of capital with a clearly defined U.S. and Europe opportunity set.
The firm’s governance lineup includes a board chaired by Mohamed Isa Al Khalifa, with vice chair roles held by Gerry Grimstone and Mubarak Abdullah Al-Mubarak Al-Sabah. BlueFive’s board also includes a roster of international figures, including Prince Turki Bin Abdulaziz Bin Farhan Al Saud, Fang Fenglei, Adah Al Mutairi, Khalid Mohamed Zaman, and Arsjad Rasjid, reflecting the firm’s stated emphasis on cross-regional relationships and operating reach alongside investment execution.
For BlueFive, the Onyx close serves as both a capital formation marker and a positioning statement. The firm is aligning Abu Dhabi as the regulatory and operational anchor, GCC sovereign capital as a strategic base, and the U.S. and European innovation markets as the target arena, with a mandate to capture upside from step-change advances in AI, life sciences, and computing. The next proof point will be the pace and profile of the initial investments, and whether the fund’s opportunistic posture translates into early, high-conviction deployments in categories where competition for top assets can be intense.
KEY QUOTES
“The Onyx Fund aims to target the current inflection points in both computational and biological intelligence, allowing us to partner with visionary entrepreneurs who are defining the next technological epoch. ADGM provides the ideal forward-looking regulatory ecosystem to anchor a fund of this global ambition.”
Hazem Ben-Gacem, founder and chief executive of BlueFive Capital
